The Discounted Cash Flow (DCF) valuation of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505.SS) is 7.38 CNY. With the latest stock price at 8.99 CNY, the upside of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd based on DCF is -17.9%.
Based on the latest price of 8.99 CNY and our DCF valuation, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505.SS) is a sell. selling 688505.SS stocks now will result in a potential gain of 17.9%.
| Range | Selected | |
| WACC / Discount Rate | 8.5% - 11.5% | 10.0% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 7.36 - 7.39 | 7.38 |
| Upside | -18.1% - -17.8% | -17.9% |